ArticleCancer research communications2025

Protein-Level Analysis of Differential Response to Chemotherapy in Triple-Negative Breast Cancer Identifies CYP1B1 as a Biomarker for Chemotherapy Resistance.

F Scott Heinemann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.